These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18450011)

  • 1. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical guide to structure-based prediction of MHC-binding peptides.
    Ranganathan S; Tong JC
    Methods Mol Biol; 2007; 409():301-8. PubMed ID: 18450010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel predictive technique for the MHC class II peptide-binding interaction.
    Davies MN; Sansom CE; Beazley C; Moss DS
    Mol Med; 2003; 9(9-12):220-5. PubMed ID: 15208743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear predictive modeling of MHC class II-peptide binding using Bayesian neural networks.
    Winkler DA; Burden FR
    Methods Mol Biol; 2007; 409():365-77. PubMed ID: 18450015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An iterative approach to class II predictions.
    Mallios RR
    Methods Mol Biol; 2007; 409():341-53. PubMed ID: 18450013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide binding to MHC class I and II proteins: new avenues from new methods.
    Yaneva R; Schneeweiss C; Zacharias M; Springer S
    Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing the modular MHC model for predicting peptide binding.
    DeLuca DS; Blasczyk R
    Methods Mol Biol; 2007; 409():261-71. PubMed ID: 18450006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the structure of bound peptide ligands to major histocompatibility complex.
    Tong JC; Tan TW; Ranganathan S
    Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the MHC-peptide affinity using some interactive-type molecular descriptors and QSAR models.
    Lin TH
    Methods Mol Biol; 2007; 409():247-60. PubMed ID: 18450005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
    Kaas Q; Lefranc MP
    In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity.
    Hattotuwagama CK; Guan P; Doytchinova IA; Flower DR
    Org Biomol Chem; 2004 Nov; 2(22):3274-83. PubMed ID: 15534705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and evaluation of MHC class II binding peptides.
    de Haan EC; Wauben MH; Grosfeld-Stulemeyer MC; Moret EE
    Biologicals; 2001; 29(3-4):289-92. PubMed ID: 11851330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
    Saito K; Oda M; Sarai A; Azuma T; Kozono H
    Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.
    Zacharias M; Springer S
    Biophys J; 2004 Oct; 87(4):2203-14. PubMed ID: 15454423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.